M J Newman

Author PubWeight™ 59.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002 3.13
2 Purification and reconstitution of functional lactose carrier from Escherichia coli. J Biol Chem 1981 2.93
3 Purification, reconstitution, and characterization of the lac permease of Escherichia coli. Methods Enzymol 1986 2.32
4 Permease-specific mutations in Salmonella typhimurium and Escherichia coli that release the glycerol, maltose, melibiose, and lactose transport systems from regulation by the phosphoenolpyruvate:sugar phosphotransferase system. J Bacteriol 1978 2.20
5 Solubilization and reconstitution of the lactose transport system from Escherichia coli. J Biol Chem 1980 1.81
6 HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 1987 1.69
7 Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol 2001 1.68
8 Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci U S A 1985 1.54
9 Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol 1992 1.42
10 Properties of a phosphoenolpyruvate: mannitol phosphotransferase system in Spirochaeta aurantia. J Biol Chem 1977 1.35
11 Determination of polycyclic aromatic hydrocarbons in the urine, benzo(a)pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res 1986 1.33
12 Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine 1994 1.28
13 Direct transfer of the phosphoryl moiety of mannitol 1-phosphate to [14C]mannitol catalyzed by the enzyme II complexes of the phosphoenolpyruvate: mannitol phosphotransferase systems in Spirochaeta aurantia and Salmonella typhimurium. J Biol Chem 1976 1.22
14 Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr Biol 1998 1.20
15 Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. J Immunol 2000 1.17
16 Lactose-proton symport by purified lac carrier protein. Biochemistry 1982 1.14
17 Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 1995 1.06
18 Solubilization and reconstitution of the melibiose carrier from a plasmid-carrying strain of Escherichia coli. J Biol Chem 1982 1.04
19 Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen. J Biol Chem 1989 1.04
20 A versatile synthetic peptide-based ELISA for identifying antibody epitopes. J Immunol Methods 1994 1.03
21 Changing pattern of bacterial isolates and antimicrobial susceptibility in neonatal infections in Korle Bu Teaching Hospital, Ghana. East Afr Med J 2007 0.95
22 Concurrent infection of human macrophages with HIV-1 and Mycobacterium avium results in decreased cell viability, increased M. avium multiplication and altered cytokine production. J Immunol 1993 0.95
23 Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases. Biochemistry 2001 0.91
24 Tick resistance and the major histocompatibility system. Aust J Exp Biol Med Sci 1984 0.86
25 Implications of Solar Evolution for the Earth's Early Atmosphere. Science 1977 0.86
26 A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice. Vaccine 2000 0.85
27 Two closely linked loci and one apparently independent locus code for bovine lymphocyte antigens. Tissue Antigens 1982 0.84
28 Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells. Cancer Res 1986 0.84
29 Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigs. AIDS Res Hum Retroviruses 1995 0.84
30 Stimulation of maternal anti-lymphocyte antibodies by first gestation bovine fetuses. J Reprod Fertil 1980 0.83
31 Analysis of alloantisera against bovine lymphocytes. Joint report of the 1st International Bovine Lymphocyte Antigen (BoLA) workshop. Anim Blood Groups Biochem Genet 1979 0.83
32 Type V collagen is an epithelial cell cycle inhibitor that is induced by and mimics the effects of transforming growth factor beta1. Cell Growth Differ 1998 0.82
33 Systematic development of a block copolymer adjuvant for trivalent influenza virus vaccine. Dev Biol Stand 1998 0.81
34 BoLA antigens are associated with increased frequency of persistent lymphocytosis in bovine leukaemia virus infected cattle and with increased incidence of antibodies to bovine leukaemia virus. Anim Genet 1988 0.81
35 In vitro measurement of antigen-specific cell-mediated immune responses using recombinant HIV-1 proteins adsorbed to latex microspheres. J Immunol Methods 1991 0.81
36 Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons . AIDS Res Hum Retroviruses 1994 0.81
37 Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulations. Vaccine 1997 0.81
38 Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer. Clin Cancer Res 1997 0.80
39 Serological and genetic identification of a bovine B lymphocyte alloantigen system. Anim Blood Groups Biochem Genet 1982 0.80
40 Evaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c-myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-beta 1. In Vitro Cell Dev Biol 1990 0.79
41 The influence of acetazolamide and amlodipine on the intracellular sodium content of rat proximal tubular cells. Br J Pharmacol 1994 0.78
42 Use of particulate forms of protein antigens to increase the sensitivity of antigen-specific proliferation assays. J Immunol Methods 1993 0.78
43 Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta. Cancer Res 1989 0.78
44 Molecular mechanics and antibody binding in the structural analysis of polycyclic aromatic hydrocarbon-diol-epoxide--DNA adducts. Carcinogenesis 1990 0.78
45 Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses. Vaccine 1999 0.78
46 The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833. Anticancer Res 1997 0.78
47 Production of foetally stimulated lymphocytotoxic antibodies by multiparous cows. Anim Blood Groups Biochem Genet 1981 0.77
48 High-performance liquid chromatography/NMR spectrometry/mass spectrometry: further advances in hyphenated technology. J Mass Spectrom 1997 0.77
49 Histocompatibility polymorphisms of domestic animals. Adv Vet Sci Comp Med 1983 0.76
50 Cryopreservation of bovine buffy coat leukocytes for use in immunologic studies. Am J Vet Res 1993 0.76
51 Identification of ethanolamine in rat and gerbil brain tissue extracts by NMR spectroscopy. NMR Biomed 1994 0.76
52 Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis. J Clin Microbiol 2000 0.76
53 The use of high vaginal, endocervical and rectal swabs in the diagnosis of genital infection in association with pre-term labour. Br J Clin Pract 1988 0.75
54 Use of fixed autologous stimulator cells to correctly present human immunodeficiency virus type 1 viral peptides to nonhuman primate lymphocytes in proliferation and cytotoxic T-lymphocyte assays. Clin Diagn Lab Immunol 1994 0.75
55 Production of foetally stimulated lymphocytotoxic antibodies by primiparous cows. Anim Blood Groups Biochem Genet 1979 0.75
56 Mixed lymphocyte reactivity in cattle. Tissue Antigens 1982 0.75
57 On-line liquid chromatography coupled with high field NMR and mass spectrometry (LC-NMR-MS): a new technique for drug metabolite structure elucidation. J Pharm Biomed Anal 1997 0.75
58 Treatment of subacute polyneuritis with corticosteroids. Can J Neurol Sci 1974 0.75
59 Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts. IARC Sci Publ 1988 0.75
60 Xenogeneic monoclonal antibodies to cell surface antigens of equine lymphocytes. Am J Vet Res 1984 0.75
61 Allogeneic antibody response in cattle. Am J Vet Res 1981 0.75
62 Cryopreservation of equine mononuclear cells for immunological studies. Vet Immunol Immunopathol 1990 0.75
63 Reconstitution of the melibiose carrier of Escherichia coli. Membr Biochem 1985 0.75
64 Potential pathogens in the lower genital tract at manual vacuum aspiration for incomplete abortion in Korle Bu Teaching Hospital, Ghana. East Afr Med J 2004 0.75
65 Prenatal diagnosis of genetic disease. Can Med Assoc J 1977 0.75
66 Total spinal following labour epidural analgesia managed with non-invasive ventilation. Anaesth Intensive Care 2010 0.75
67 Antibodies to the neural cell adhesion molecule disrupt functional recovery in injured nerves. Exp Neurol 1990 0.75
68 Intrathecal catheters and epidural blood patching. Int J Obstet Anesth 2009 0.75
69 Infection control in Africa south of the Sahara. Infect Control Hosp Epidemiol 2001 0.75
70 Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes. Cell Immunol 1994 0.75
71 Interstellar cloud material: contribution to planetary atmospheres. Science 1978 0.75
72 Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein. Virology 1986 0.75
73 Preliminary report on the isolation of a dysgonic variety of Microsporum canis together with the normal variety from a cattery. Mycopathologia 1992 0.75
74 Novel adjuvants for induction of T-cell and antibody responses to encephalitogenic and regulatory determinants in Lewis rats. Vaccine 1998 0.75
75 Cerebro--spinal fluid. Why, when & what for? Manit Med Rev 1968 0.75
76 The antibody response to bovine lymphocyte alloantigens. Vet Immunol Immunopathol 1983 0.75
77 Efficiency of convection and time variation of the solar constant. Science 1978 0.75
78 Vaginal flora of first time urban family planning attendants in Accra, Ghana. West Afr J Med 2005 0.75